Align Technology Inc (ALGN) stock
ALGNNasdaqOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 13/3012% below fair value
$163.46−2.52 (-1.52%)
Close on Nov 17, 2026Market cap $11.61BP/E 28.4Yield –
Align Technology r&d expenses
Research and development expenses are spending on new products and technology.
Align Technology's R&D Expenses for the twelve months ending Jun 30, 2026 was $377.00M, up 0.9% year over year. For fiscal 2025 it was $369.91M, up 1.6% from the year before. Over ten years it grew 19.7% a year on average. The highest annual figure on record is $369.91M in fiscal 2025.
Annual r&d expenses
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $369.91M | +1.6% |
| FY2024 | Dec 31, 2024 | $364.20M | +5.0% |
| FY2023 | Dec 31, 2023 | $346.83M | +13.6% |
| FY2022 | Dec 31, 2022 | $305.26M | +21.9% |
| FY2021 | Dec 31, 2021 | $250.32M | +42.8% |
| FY2020 | Dec 31, 2020 | $175.31M | +11.4% |
| FY2019 | Dec 31, 2019 | $157.36M | +22.1% |
| FY2018 | Dec 31, 2018 | $128.90M | +32.1% |
| FY2017 | Dec 31, 2017 | $97.56M | +28.8% |
| FY2016 | Dec 31, 2016 | $75.72M | +23.7% |
| FY2015 | Dec 31, 2015 | $61.24M | +16.0% |
| FY2014 | Dec 31, 2014 | $52.80M | +19.8% |
| FY2013 | Dec 31, 2013 | $44.08M | +2.8% |
| FY2012 | Dec 31, 2012 | $42.87M | +15.4% |
| FY2011 | Dec 31, 2011 | $37.15M | +42.9% |
| FY2010 | Dec 31, 2010 | $26.00M | +16.8% |
| FY2009 | Dec 31, 2009 | $22.25M | -15.0% |
| FY2008 | Dec 31, 2008 | $26.17M | – |
Quarterly r&d expenses
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $102.03M | +5.8% |
| Q1 FY2026 | Mar 31, 2026 | $98.66M | +1.5% |
| Q4 FY2025 | Dec 31, 2025 | $83.04M | -12.5% |
| Q3 FY2025 | Sep 30, 2025 | $93.28M | +9.4% |
| Q2 FY2025 | Jun 30, 2025 | $96.40M | +4.6% |
| Q1 FY2025 | Mar 31, 2025 | $97.20M | +5.8% |
| Q4 FY2024 | Dec 31, 2024 | $94.88M | +15.5% |
| Q3 FY2024 | Sep 30, 2024 | $85.27M | -3.9% |
| Q2 FY2024 | Jun 30, 2024 | $92.19M | +4.2% |
| Q1 FY2024 | Mar 31, 2024 | $91.86M | +5.0% |
| Q4 FY2023 | Dec 31, 2023 | $82.16M | -1.6% |
| Q3 FY2023 | Sep 30, 2023 | $88.74M | +15.3% |
| Q2 FY2023 | Jun 30, 2023 | $88.49M | +21.3% |
| Q1 FY2023 | Mar 31, 2023 | $87.45M | +21.8% |
| Q4 FY2022 | Dec 31, 2022 | $83.52M | +15.2% |
| Q3 FY2022 | Sep 30, 2022 | $76.97M | +17.3% |
| Q2 FY2022 | Jun 30, 2022 | $72.97M | +26.4% |
| Q1 FY2022 | Mar 31, 2022 | $71.81M | +31.7% |
| Q4 FY2021 | Dec 31, 2021 | $72.48M | +48.3% |
| Q3 FY2021 | Sep 30, 2021 | $65.59M | +47.3% |
| Q2 FY2021 | Jun 30, 2021 | $57.72M | +43.0% |
| Q1 FY2021 | Mar 31, 2021 | $54.54M | +31.3% |
| Q4 FY2020 | Dec 31, 2020 | $48.89M | +18.3% |
| Q3 FY2020 | Sep 30, 2020 | $44.53M | +12.2% |
| Q2 FY2020 | Jun 30, 2020 | $40.36M | +3.9% |
| Q1 FY2020 | Mar 31, 2020 | $41.53M | +10.7% |
| Q4 FY2019 | Dec 31, 2019 | $41.33M | +15.4% |
| Q3 FY2019 | Sep 30, 2019 | $39.68M | +21.3% |
| Q2 FY2019 | Jun 30, 2019 | $38.85M | +26.1% |
| Q1 FY2019 | Mar 31, 2019 | $37.50M | +26.7% |
| Q4 FY2018 | Dec 31, 2018 | $35.80M | +36.8% |
| Q3 FY2018 | Sep 30, 2018 | $32.70M | +35.1% |
| Q2 FY2018 | Jun 30, 2018 | $30.80M | +26.3% |
| Q1 FY2018 | Mar 31, 2018 | $29.59M | +29.8% |
| Q4 FY2017 | Dec 31, 2017 | $26.17M | +21.1% |
| Q3 FY2017 | Sep 30, 2017 | $24.20M | +18.5% |
| Q2 FY2017 | Jun 30, 2017 | $24.38M | – |
| Q1 FY2017 | Mar 31, 2017 | $22.80M | – |
| Q4 FY2016 | Dec 31, 2016 | $21.61M | – |
| Q3 FY2016 | Sep 30, 2016 | $20.42M | – |
See a number that looks wrong?